Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
Stefan K. Barta(University of Pennsylvania), Joseph A. Sparano(Tisch Cancer Institute), Lionel Galicier(Hôpital de la Timone), Mireia Morgades(Josep Carreras Leukaemia Research Institute), Wyndham H. Wilson(National Institutes of Health), Richard F. Little(Dana-Farber Cancer Institute), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Albert Oriol(Institut Català d'Oncologia), Jeannette Y. Lee(University of Arkansas at Little Rock), Scot C. Remick(University Hospitals of Cleveland), Lawrence D. Kaplan(UCSF Helen Diller Family Comprehensive Cancer Center), Kieron Dunleavy(National Cancer Institute), Lee Ratner(Washington University in St. Louis), Michele Spina(National Cancer Institute), Josep‐María Ribera(Universitat Autònoma de Barcelona), Roni Tamari(Memorial Sloan Kettering Cancer Center), Christoph Wyen, Xiaonan Xue(Albert Einstein College of Medicine), Olga García(Institut Català d'Oncologia), Umberto Tirelli(National Cancer Institute), François Boué(Inserm), Rudolf Weiß, Nicolas Mounier(Centre Hospitalier Universitaire de Nice), Dan Wang(Breast Cancer Now), Ariela Noy(Memorial Sloan Kettering Cancer Center)
Cited by 189
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k